Skip to main content
NoticePayment processing is currently down, so we are not taking new orders right now. Thank you for your patience.
For laboratory research use only. Not for human or veterinary use.
Free UPS Ground on 3+ vials · same business day by 2 PM ET
BPC-157 + TB-500Preclinical

Thymosin beta4 accelerates wound healing

Malinda KM, Sidhu GS, Mani H, et al. · J Invest Dermatol · 1999
PMID: 10469335 · DOI: 10.1046/j.1523-1747.1999.00608.x
Summary

Rat full-thickness dermal wound model characterizing systemic and topical thymosin beta 4. Endpoints: wound area closure rate, re-epithelialization, collagen deposition over the healing window.

Read the full citation on PubMed

Citation hosted by NCBI. We link to the source so the researcher can read the abstract, full text, or references-cited list directly.

Compounds referenced in this study
  • TB-500 (Long Chain)
    Synthetic acetylated thymosin-β4 (1-43) analog. Studied in tissue-regeneration research.
    View product →
Guides covering this compound
More BPC-157 + TB-500 citations
Browse the catalog